Abeona Non Operating Income Net Other vs Total Operating Expenses Analysis
ABEO Stock | USD 5.98 0.06 1.01% |
Abeona Therapeutics financial indicator trend analysis is way more than just evaluating Abeona Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Abeona Therapeutics is a good investment. Please check the relationship between Abeona Therapeutics Non Operating Income Net Other and its Total Operating Expenses accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abeona Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.
Non Operating Income Net Other vs Total Operating Expenses
Non Operating Income Net Other vs Total Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Abeona Therapeutics Non Operating Income Net Other account and Total Operating Expenses. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Abeona Therapeutics' Non Operating Income Net Other and Total Operating Expenses is -0.03. Overlapping area represents the amount of variation of Non Operating Income Net Other that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of Abeona Therapeutics, assuming nothing else is changed. The correlation between historical values of Abeona Therapeutics' Non Operating Income Net Other and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Operating Income Net Other of Abeona Therapeutics are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Non Operating Income Net Other i.e., Abeona Therapeutics' Non Operating Income Net Other and Total Operating Expenses go up and down completely randomly.
Correlation Coefficient | -0.03 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Non Operating Income Net Other
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most indicators from Abeona Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Abeona Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abeona Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.At this time, Abeona Therapeutics' Issuance Of Capital Stock is very stable compared to the past year. As of the 11th of December 2024, Sales General And Administrative To Revenue is likely to grow to 10.49, while Selling General Administrative is likely to drop about 18.1 M.
Abeona Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Abeona Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Abeona Therapeutics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 223.4M | 151.2M | 79.6M | 64.2M | 64.0M | 49.3M | |
Short Long Term Debt Total | 8.0M | 8.7M | 9.4M | 7.6M | 5.4M | 7.9M | |
Other Current Liab | 32.9M | 33.2M | 8.4M | 2.4M | 9.6M | 5.1M | |
Total Current Liabilities | 38.7M | 42.0M | 16.6M | 7.8M | 13.4M | 9.8M | |
Total Stockholder Equity | 178.4M | 102.6M | 51.4M | 26.8M | 14.8M | 28.6M | |
Net Debt | (121.3M) | (3.9M) | (23.6M) | (6.6M) | (9.1M) | (9.5M) | |
Retained Earnings | (486.5M) | (570.7M) | (655.6M) | (695.3M) | (749.5M) | (712.0M) | |
Accounts Payable | 3.8M | 4.7M | 4.3M | 1.8M | 1.9M | 2.5M | |
Cash | 129.3M | 12.6M | 32.9M | 14.2M | 14.5M | 19.9M | |
Cash And Short Term Investments | 129.3M | 95.0M | 45.0M | 52.1M | 52.2M | 30.8M | |
Common Stock Total Equity | 469K | 479K | 836K | 961K | 1.1M | 1.2M | |
Common Stock Shares Outstanding | 2.0M | 3.7M | 3.9M | 7.9M | 21.4M | 22.4M | |
Liabilities And Stockholders Equity | 223.4M | 151.2M | 79.6M | 64.2M | 64.0M | 49.3M | |
Non Current Liabilities Total | 6.3M | 6.7M | 11.6M | 29.7M | 35.8M | 37.5M | |
Other Current Assets | 3.1M | 5.4M | 8.3M | 762K | 1.1M | 1.2M | |
Other Stockholder Equity | 664.1M | 672.3M | 705.6M | 722.0M | 764.2M | 802.4M | |
Total Liab | 45.0M | 48.6M | 28.2M | 37.5M | 49.2M | 51.6M | |
Total Current Assets | 132.4M | 97.7M | 56.3M | 53.1M | 55.7M | 32.7M | |
Common Stock | 836K | 961K | 1.5M | 177K | 265K | 417.6K | |
Property Plant And Equipment Net | 21.2M | 18.4M | 21.7M | 11.1M | 8.0M | 8.4M | |
Non Current Assets Total | 91.0M | 53.5M | 23.3M | 11.1M | 8.3M | 7.9M | |
Non Currrent Assets Other | 1.1M | 1.1M | 168K | 43K | 277K | 319.9K | |
Property Plant And Equipment Gross | 21.2M | 18.4M | 21.7M | 11.1M | 21.0M | 22.0M | |
Short Term Debt | 1.7M | 3.8M | 3.6M | 3.5M | 2.0M | 2.5M | |
Intangible Assets | 43.0M | 36.2M | 1.5M | 1.4M | 1.6M | 1.5M | |
Other Assets | 1.1M | 1.1M | 1.1M | 43K | 38.7K | 36.8K | |
Property Plant Equipment | 13.2M | 18.4M | 21.7M | 11.1M | 12.7M | 13.4M | |
Other Liab | 3.1M | 20M | 4.0M | 23.8M | 27.4M | 28.8M | |
Retained Earnings Total Equity | (359.8M) | (410.2M) | (486.5M) | (570.7M) | (513.6M) | (488.0M) | |
Net Tangible Assets | 178.4M | 68.6M | 50.0M | 26.8M | 30.8M | 29.2M | |
Capital Surpluse | 529.4M | 543.8M | 664.1M | 672.3M | 773.1M | 518.5M |
Pair Trading with Abeona Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abeona Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abeona Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Abeona Stock
Moving against Abeona Stock
The ability to find closely correlated positions to Abeona Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abeona Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abeona Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abeona Therapeutics to buy it.
The correlation of Abeona Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abeona Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abeona Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abeona Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abeona Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abeona Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.05) | Quarterly Revenue Growth (1.00) | Return On Assets (0.38) | Return On Equity (1.27) |
The market value of Abeona Therapeutics is measured differently than its book value, which is the value of Abeona that is recorded on the company's balance sheet. Investors also form their own opinion of Abeona Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Abeona Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abeona Therapeutics' market value can be influenced by many factors that don't directly affect Abeona Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abeona Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abeona Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abeona Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.